Gastric Cancer (Diagnosis)
14
4
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Exercise Training After Upper Gastrointestinal Cancer Surgery
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)
The UGIRA International Registry for RAMIG for Gastric Cancer
A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal
The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagnosis of Gastric Cancer and Related Diseases
High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Peri-habilitation for Patients With Gastric Cancer
Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric Cancer
Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD
Clinical Study of Weifuchun Treatment on Gastric Cancer
Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer